Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYECO GROUP LTD Board/Management Information 2013

Oct 6, 2013

65304_rns_2013-10-06_81329a07-d5de-41b1-b86e-29233d81e1f7.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [588 x 74] intentionally omitted <==

==> picture [588 x 75] intentionally omitted <==

TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED

DATE: 7 October 2013

DIRECTOR APPOINTMENT

The Board of Cardia Bioplastics Limited (“Cardia” or the “Company”) is pleased to announce the appointment of Mr. Steven Bendel to the Cardia Board.

Mr.Bendel’s qualifications include a Bachelor of Education degree from Victoria College-Rusden with a Graduate Diploma of Business (Accounting) from Monash University. Mr.Bendel is also a member of CPA Australia.

Mr.Bendel currently is a sole proprietor of accountancy practice-Bendel Partners Pty Ltd. Through his accountancy practice, Mr.Bendel has experience dealing with a diverse range of clientele ranging from small and medium sized business (including a law firm, medical & dental service providers, financiers, importers and wholesalers, property developers), single and multi-tenanted commercial property investors & syndicates (suburban & regional shopping centres, bulky good clearance centres, child care facilities, national fast food outlets, factories, warehouses, residential and an aged accommodation facility) and is also actively involved in property syndications, property development, lease negotiations, sourcing and negotiating finance (short and long term) with major lending institutions.

The Directors welcome appointment of Mr.Bendel and look forward to his contribution to the Company as a NonExecutive Director.

Appendix 3X is attached for Mr.Bendel, outlining his Initial Interest in Cardia.

Pat Volpe Chairman

==> picture [593 x 62] intentionally omitted <==

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity - Cardia Bioplastics Limited

ABN- 89 064 755 237

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr. Steven Bendel
Date of appointment 7 October 2013

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

20,000,000 -Fully Paid Ordinary Shares

  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Number & class of Securities
Note: Provide details of the circumstances giving
rise to the relevant interest.
Bendel Family Superannuation Fund 20,000,000- Fully Paid Ordinary Shares
Direct-Beneficiary

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a
Nature of interest n/a
Name of registered holder n/a
(if issued securities)
No. and class of securities to which n/a
interest relates
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002